• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ISORAY MEDICAL, INC. / SHANNON GOLDENSTEIN PROXCELAN MODEL CS-1; CS-1 CESIUM-131 BRACHYTHERAPY SEEDS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ISORAY MEDICAL, INC. / SHANNON GOLDENSTEIN PROXCELAN MODEL CS-1; CS-1 CESIUM-131 BRACHYTHERAPY SEEDS Back to Search Results
Model Number CS-1
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Inflammation (1932)
Event Type  Injury  
Manufacturer Narrative
Manufacturer representative observed this case, wherein 9 individual isoray cesium-131 sources ("seeds") were implanted into a vulvar tumor.This representative reports that rather than the customary 1.0 cm spacing of sources implanted into the tumor, the physician placed the sources at 0.5 cm apart.Manufacturer believes that the placing of sources closer together than 1.0 cm may have caused excessive radiation dose to be deposited, thereby possibly contributing to this adverse event.Additionally, prior to the cesium-131 seed implant this patient underwent a course of external beam radiation therapy, which on its own or in combination with the cesium-131 seed implant may have contributed to this adverse event.Manufacturer has made multiple attempts to contact the physician involved in this case in order to obtain more specifics, however no reply has been received.
 
Event Description
During a customer service follow-up with the facility, 22 days post implant, isoray was notified that the patient "got proctitis and a colorectal surgeon diverted her with a colostomy." while clarifying if the issue had connection to the implant, the facility suggested that the temporal course of the complication suggests that the implant was associated with the development of the adverse event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROXCELAN MODEL CS-1
Type of Device
CS-1 CESIUM-131 BRACHYTHERAPY SEEDS
Manufacturer (Section D)
ISORAY MEDICAL, INC. / SHANNON GOLDENSTEIN
350 hills street, ste., 106
richland, wa WA 99354
Manufacturer Contact
shannon goldenstein
350 hills street., suite., 106
richland, WA 99354
5093751202
MDR Report Key9284730
MDR Text Key165261202
Report Number3005520039-2019-00001
Device Sequence Number1
Product Code KXK
UDI-Device IdentifierM748CS10
UDI-PublicM748CS10
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K030162
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Physician
Remedial Action Patient Monitoring
Type of Report Initial
Report Date 10/24/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/06/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/04/2019
Device Model NumberCS-1
Device Catalogue NumberN/A
Device Lot NumberDO1935-021
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/27/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/29/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age18 YR
-
-